86 FR 234 pg. 70148 - Bulk Manufacturer of Controlled Substances Application: Noramco Coventry LLC

Type: NOTICEVolume: 86Number: 234Page: 70148
Docket number: [Docket No. DEA-928]
FR document: [FR Doc. 2021-26676 Filed 12-8-21; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version:  PDF Version
Page: 70148

[top] page 70148

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-928]

Bulk Manufacturer of Controlled Substances Application: Noramco Coventry LLC

AGENCY:

Drug Enforcement Administration, Justice.

ACTION:

Notice of application.

SUMMARY:

Noramco Coventry LLC, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

DATES:

Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 7, 2022. Such persons may also file a written request for a hearing on the application on or before February 7, 2022.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on September 29, 2021, Noramco Coventry LLC, 498 Washington Street, Coventry, Rhode Island 02816, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

Controlled substance Drug code Schedule
Marihuana 7360 I
Tetrahydrocannabinols 7370 I
Dihydromorphine 9145 I
Methylphenidate 1724 II
Oxycodone 9143 II
Hydromorphone 9150 II
Hydrocodone 9193 II
Levorphanol 9220 II
Morphine 9300 II
Oripavine 9330 II
Thebaine 9333 II
Oxymorphone 9652 II
Noroxymorphone 9668 II
Tapentadol 9780 II

The company plans to bulk manufacture the listed controlled substances for use as intermediates and converted to other controlled substances or for sale to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration.

Brian S. Besser,

Acting Assistant Administrator.

[FR Doc. 2021-26676 Filed 12-8-21; 8:45 am]

BILLING CODE P